NCT03605498 is a clinical trial in Bacterial Infections, sponsored by Sundara Reddy.

Who is sponsoring NCT03605498?

NCT03605498 is sponsored by Sundara Reddy.

What condition does NCT03605498 study?

NCT03605498 studies Bacterial Infections.

Is NCT03605498 still recruiting?

NCT03605498 is currently completed. Last updated 1 March 2019.

Last reviewed 2019-03-01 · How we verify

NCT03605498

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

OR PathTrac (Tracking Intra-operative Bacterial Transmission)

Completed Last updated 1 March 2019

What this trial tests

trial in Bacterial Infections in 83 participants. Completed in 12 February 2018.

Timeline

5 September 2017

Primary endpoint
12 February 2018

12 February 2018

Quick facts

Lead sponsor	Sundara Reddy
Status	Completed
Study type	OBSERVATIONAL
Enrollment	83
Start date	5 September 2017
Primary completion	12 February 2018
Estimated completion	12 February 2018
Sites	1 location across United States

Conditions studied

Bacterial Infections — all drugs for Bacterial Infections →

Sponsor

Sundara Reddy — full company profile →

Who can join

Adults 18 to 105, any sex, with Bacterial Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Healthcare-associated infections occur frequently and are associated with patient harm. These infections are becoming more difficult to treat due to antibiotic resistance. It is important that healthcare facilities take the steps necessary to prevent the spread of resistant bacteria between patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bacterial Infections

Currently open trials in the same condition.

NCT07017777 — A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infant · Phase 3 · recruiting
NCT07104162 — A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal I · Phase 1 · recruiting
NCT07207291 — Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers · Phase 1 · recruiting
NCT07056881 — Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa · recruiting
NCT06592586 — A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women · Phase 2, PHASE3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03605498 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sundara Reddy
Last refreshed: 1 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03605498.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing